Risperdal Consta Approved for Bipolar Disorder - Forbes
MONDAY, May 18 (HealthDay News) — The Janssen Pharmaceuticals drug Risperdal Consta (risperidone) has been approved by the U.S. Food and Drug Administration for people with Bipolar 1 disorder, the drug maker said Monday. Risperdal Consta is the long …